EUVIMEDEUVIMED entdecken
EditorialKommentarKohortenstudie

Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study

Francisco González, Sebastián Chávez, Fabián Miranda

Journal of Antimicrobial Chemotherapy · 03.06.2026 · 81 (7)

DOI: 10.1093/jac/dkag208 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 17.06.2026. Verfasst von Francisco González und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Clínico de la Universidad de Chile, Dr. Carlos Lorca Tobar 999, Independencia, Santiago, Chile. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Internal Medicine Department, Hospital Clínico de la Universidad de Chile, Dr. Carlos Lorca Tobar 999, Independencia, Santiago, Chile.

Zitieren

APA

González, F., Chávez, S., & Miranda, F. (2026). Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study. Journal of Antimicrobial Chemotherapy, 81(7). https://doi.org/10.1093/jac/dkag208

Vancouver

González F, Chávez S, Miranda F. Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2026;81(7). doi:10.1093/jac/dkag208

BibTeX
@article{Gonzlez2026,
  author = {González, Francisco and Chávez, Sebastián and Miranda, Fabián},
  title = {Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {7},
  doi = {10.1093/jac/dkag208}
}
Kostenlos starten →